Circulation, Vol 90, 653-657, Copyright © 1994 by American Heart Association
MA Movsesian, M Karimi, K Green and LR Jones
BACKGROUND: Observations of abnormalities in the diastolic components of
intracellular Ca2+ transients in failing human left ventricular myocardium
have raised the possibility that reductions in the level or function of
sarcoplasmic reticulum proteins involved in Ca2+ transport contribute to
the pathophysiology of dilated cardiomyopathy in humans. Functional assays,
however, have revealed no differences in ATP- dependent Ca2+ transport or
its modulation by phospholamban in sarcoplasmic reticulum-enriched
microsomes prepared from nonfailing and failing human left ventricular
myocardium. The purpose of the present study was to quantify protein levels
of Ca(2+)-transporting ATPase, phospholamban, and calsequestrin directly in
nonfailing and failing human left ventricular myocardium. METHOD AND
RESULTS: Total protein extracts were prepared from nonfailing left
ventricular myocardium from the hearts of unmatched organ donors with
normal left ventricular contractility (n = 6) and from failing left
ventricular myocardium from the excised hearts of transplant recipients
with class IV heart failure resulting from idiopathic dilated
cardiomyopathy (n = 6). Ca(2+)- transporting ATPase, phospholamban, and
calsequestrin contents were determined by quantitative immunoblotting with
monoclonal and affinity- purified polyclonal antibodies. The levels of the
three proteins were identical in nonfailing and failing human left
ventricular myocardium. CONCLUSIONS: These results indicate that protein
levels of Ca(2+)- transporting ATPase, phospholamban, and calsequestrin are
not diminished in failing human left ventricular myocardium and that
downregulation of the Ca(2+)-transporting ATPase and phospholamban is not
part of the molecular pathophysiology of dilated cardiomyopathy in humans.
ARTICLES
Ca(2+)-transporting ATPase, phospholamban, and calsequestrin levels in nonfailing and failing human myocardium
Department of Internal Medicine (Cardiology), Salt Lake City Veterans Affairs Medical Center, UT.
This article has been cited by other articles:
![]() |
M. Periasamy, P. Bhupathy, and G. J. Babu Regulation of sarcoplasmic reticulum Ca2+ ATPase pump expression and its relevance to cardiac muscle physiology and pathology Cardiovasc Res, January 15, 2008; 77(2): 265 - 273. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. T. McCloskey, S. Turcato, G.-Y. Wang, L. Turnbull, B.-Q. Zhu, T. Bambino, A. P. Nguyen, D. H. Lovett, R. A. Nissenson, J. S. Karliner, et al. Expression of a Gi-coupled receptor in the heart causes impaired Ca2+ handling, myofilament injury, and dilated cardiomyopathy Am J Physiol Heart Circ Physiol, January 1, 2008; 294(1): H205 - H212. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Chen-Izu, L. Chen, T. Banyasz, S. L. McCulle, B. Norton, S. M. Scharf, A. Agarwal, A. Patwardhan, L. T. Izu, and C. W. Balke Hypertension-induced remodeling of cardiac excitation-contraction coupling in ventricular myocytes occurs prior to hypertrophy development Am J Physiol Heart Circ Physiol, December 1, 2007; 293(6): H3301 - H3310. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. M. Prasad, H. Ma, C. Sumbilla, D. I. Lee, M. G. Klein, and G. Inesi Phenylephrine hypertrophy, Ca2+-ATPase (SERCA2), and Ca2+ signaling in neonatal rat cardiac myocytes Am J Physiol Cell Physiol, June 1, 2007; 292(6): C2269 - C2275. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. P. L. Rolim, A. Medeiros, K. T. Rosa, K. C. Mattos, M. C. Irigoyen, E. M. Krieger, J. E. Krieger, C. E. Negrao, and P. C. Brum Exercise training improves the net balance of cardiac Ca2+ handling protein expression in heart failure Physiol Genomics, May 11, 2007; 29(3): 246 - 252. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Nattel, A. Maguy, S. Le Bouter, and Y.-H. Yeh Arrhythmogenic Ion-Channel Remodeling in the Heart: Heart Failure, Myocardial Infarction, and Atrial Fibrillation Physiol Rev, April 1, 2007; 87(2): 425 - 456. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. E. Litwin "Ryanogate": Who Leaked the Calcium? Circ. Res., February 3, 2006; 98(2): 165 - 168. [Full Text] [PDF] |
||||
![]() |
C. A. Emter, S. A. McCune, G. C. Sparagna, M. J. Radin, and R. L. Moore Low-intensity exercise training delays onset of decompensated heart failure in spontaneously hypertensive heart failure rats Am J Physiol Heart Circ Physiol, November 1, 2005; 289(5): H2030 - H2038. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Rocchetti, A. Besana, G. Mostacciuolo, R. Micheletti, P. Ferrari, S. Sarkozi, C. Szegedi, I. Jona, and A. Zaza Modulation of Sarcoplasmic Reticulum Function by Na+/K+ Pump Inhibitors with Different Toxicity: Digoxin and PST2744 [(E,Z)-3-((2-Aminoethoxy)imino)androstane-6,17-dione Hydrochloride] J. Pharmacol. Exp. Ther., April 1, 2005; 313(1): 207 - 215. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. J. Lokuta, N. A. Maertz, S. V. Meethal, K. T. Potter, T. J. Kamp, H. H. Valdivia, and R. A. Haworth Increased Nitration of Sarcoplasmic Reticulum Ca2+-ATPase in Human Heart Failure Circulation, March 1, 2005; 111(8): 988 - 995. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Wasson, H. K. Reddy, and M. L. Dohrmann Current Perspectives of Electrical Remodeling and Its Therapeutic Implications Journal of Cardiovascular Pharmacology and Therapeutics, April 1, 2004; 9(2): 129 - 144. [Abstract] [PDF] |
||||
![]() |
T. Zhang, S. Miyamoto, and J. H. Brown Cardiomyocyte Calcium and Calcium/Calmodulin-dependent Protein Kinase II: Friends or Foes? Recent Prog. Horm. Res., January 1, 2004; 59(1): 141 - 168. [Abstract] [Full Text] |
||||
![]() |
R. H. G. Schwinger and K. F. Frank Calcium and the Failing Heart: Phospholamban, Good Guy or Bad Guy? Sci. Signal., April 29, 2003; 2003(180): pe15 - pe15. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. M Pogwizd, K. R Sipido, F. Verdonck, and D. M Bers Intracellular Na in animal models of hypertrophy and heart failure: contractile function and arrhythmogenesis Cardiovasc Res, March 15, 2003; 57(4): 887 - 896. [Full Text] [PDF] |
||||
![]() |
K. F Frank, B. Bolck, E. Erdmann, and R. H.G Schwinger Sarcoplasmic reticulum Ca2+-ATPase modulates cardiac contraction and relaxation Cardiovasc Res, January 1, 2003; 57(1): 20 - 27. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. M. Misquitta, J. Mwanjewe, L. Nie, and A. K. Grover Sarcoplasmic reticulum Ca2+ pump mRNA stability in cardiac and smooth muscle: role of the 3'-untranslated region Am J Physiol Cell Physiol, August 1, 2002; 283(2): C560 - C568. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Kneller, H. Sun, N. Leblanc, and S. Nattel Remodeling of Ca2+-handling by atrial tachycardia: evidence for a role in loss of rate-adaptation Cardiovasc Res, May 1, 2002; 54(2): 416 - 426. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. B Sande, I. Sjaastad, I. B Hoen, J. Bokenes, T. Tonnessen, E. Holt, P. K Lunde, and G. Christensen Reduced level of serine16 phosphorylated phospholamban in the failing rat myocardium: a major contributor to reduced SERCA2 activity Cardiovasc Res, February 1, 2002; 53(2): 382 - 391. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Kubo, K. B. Margulies, V. Piacentino III, J. P. Gaughan, and S. R. Houser Patients With End-Stage Congestive Heart Failure Treated With {beta}-Adrenergic Receptor Antagonists Have Improved Ventricular Myocyte Calcium Regulatory Protein Abundance Circulation, August 28, 2001; 104(9): 1012 - 1018. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Lemire, A. Ducharme, J.-C. Tardif, F. Poulin, L. R. Jones, B. G. Allen, T. E. Hebert, and H. Rindt Cardiac-directed overexpression of wild-type {alpha}1B-adrenergic receptor induces dilated cardiomyopathy Am J Physiol Heart Circ Physiol, August 1, 2001; 281(2): H931 - H938. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Kline, T. Jiang, X. Xu, V. O. Rybin, and S. F. Steinberg Abnormal calcium and protein kinase C-{epsilon} signaling in hypertrophied atrial tumor myocytes (AT-1 cells) Am J Physiol Heart Circ Physiol, June 1, 2001; 280(6): H2761 - H2769. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. G. Hampton, J.-F. Wang, J. DeAngelis, I. Amende, K. D. Philipson, and J. P. Morgan Enhanced gene expression of Na+/Ca2+ exchanger attenuates ischemic and hypoxic contractile dysfunction Am J Physiol Heart Circ Physiol, December 1, 2000; 279(6): H2846 - H2854. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. E. Litwin, D. Zhang, and J. H. B. Bridge Dyssynchronous Ca2+ Sparks in Myocytes From Infarcted Hearts Circ. Res., November 24, 2000; 87(11): 1040 - 1047. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. M. Pogwizd Increased Na+-Ca2+ Exchanger in the Failing Heart Circ. Res., October 13, 2000; 87(8): 641 - 643. [Full Text] [PDF] |
||||
![]() |
L. Sen, G. Cui, G. C. Fonarow, and H. Laks Differences in mechanisms of SR dysfunction in ischemic vs. idiopathic dilated cardiomyopathy Am J Physiol Heart Circ Physiol, August 1, 2000; 279(2): H709 - H718. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Munch, B. Bolck, K. Brixius, H. Reuter, U. Mehlhorn, W. Bloch, and R. H. G. Schwinger SERCA2a activity correlates with the force-frequency relationship in human myocardium Am J Physiol Heart Circ Physiol, June 1, 2000; 278(6): H1924 - H1932. [Abstract] [Full Text] [PDF] |
||||
![]() |
U. Kreuzberg, P. Theissen, H. Schicha, F. Schroder, U. Mehlhorn, E. R. de Vivie, P. Boknik, J. Neumann, C. Grohe, and S. Herzig Single-channel activity and expression of atrial L-type Ca2+ channels in patients with latent hyperthyroidism Am J Physiol Heart Circ Physiol, March 1, 2000; 278(3): H723 - H730. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. G Matteo and C. S. Moravec Immunolocalization of annexins IV, V and VI in the failing and non-failing human heart Cardiovasc Res, March 1, 2000; 45(4): 961 - 970. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. A. Walker, F. A. Crawford Jr, and F. G. Spinale MYOCYTE CONTRACTILE DYSFUNCTION WITH HYPERTROPHY AND FAILURE: RELEVANCE TO CARDIAC SURGERY J. Thorac. Cardiovasc. Surg., February 1, 2000; 119(2): 388 - 400. [Full Text] [PDF] |
||||
![]() |
B. Linck and W. Schmitz Messenger RNA expression and immunological quantification of phospholamban and SR-Ca2+-ATPase in failing and nonfailing human hearts Cardiovasc Res, January 1, 2000; 45(1): 243 - 244. [Full Text] [PDF] |
||||
![]() |
U Ravens and D Dobrev Regulation of sarcoplasmic reticulum Ca2+-ATPase and phospholamban in the failing and nonfailing heart Cardiovasc Res, January 1, 2000; 45(1): 245 - 252. [Full Text] [PDF] |
||||
![]() |
W. H. Barry Molecular Inotropy : A Future Approach to the Treatment of Heart Failure? Circulation, December 7, 1999; 100(23): 2303 - 2304. [Full Text] [PDF] |
||||
![]() |
X.-Q. Zhang, Y.-C. Ng, R. L. Moore, T. I. Musch, and J. Y. Cheung In situ SR function in postinfarction myocytes J Appl Physiol, December 1, 1999; 87(6): 2143 - 2150. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. M. Pogwizd, M. Qi, W. Yuan, A. M. Samarel, and D. M. Bers Upregulation of Na+/Ca2+ Exchanger Expression and Function in an Arrhythmogenic Rabbit Model of Heart Failure Circ. Res., November 26, 1999; 85(11): 1009 - 1019. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Huang, S. Wang, D. Qin, M. Boutjdir, and N. El-Sherif Diminished Basal Phosphorylation Level of Phospholamban in the Postinfarction Remodeled Rat Ventricle : Role of {beta}-Adrenergic Pathway, Gi Protein, Phosphodiesterase, and Phosphatases Circ. Res., October 29, 1999; 85(9): 848 - 855. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. A. Fallavollita, S. Jacob, R. F. Young, and J. M. Canty Jr. Regional alterations in SR Ca2+-ATPase, phospholamban, and HSP-70 expression in chronic hibernating myocardium Am J Physiol Heart Circ Physiol, October 1, 1999; 277(4): H1418 - H1428. [Abstract] [Full Text] [PDF] |
||||
![]() |
U. Schmidt, R. J. Hajjar, C. S. Kim, D. Lebeche, A. A. Doye, and J. K. Gwathmey Human heart failure: cAMP stimulation of SR Ca2+-ATPase activity and phosphorylation level of phospholamban Am J Physiol Heart Circ Physiol, August 1, 1999; 277(2): H474 - H480. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Prestle, S. Dieterich, M. Preuss, U. Bieligk, and G. Hasenfuss Heterogeneous transmural gene expression of calcium-handling proteins and natriuretic peptides in the failing human heart Cardiovasc Res, August 1, 1999; 43(2): 323 - 331. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Boknik, C. Unkel, U. Kirchhefer, U. Kleideiter, O. Klein-Wiele, J. Knapp, B. Linck, H. Luss, F. Ulrich Muller, W. Schmitz, et al. Regional expression of phospholamban in the human heart Cardiovasc Res, July 1, 1999; 43(1): 67 - 76. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. J. Owen, P. B. J. Burton, M. C. Michel, O. Zolk, M. Bohm, J. R. Pepper, P. J. R. Barton, M. H. Yacoub, and S. E. Harding Myocardial Dysfunction in Donor Hearts : A Possible Etiology Circulation, May 18, 1999; 99(19): 2565 - 2570. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. F. Tomaselli and E. Marban Electrophysiological remodeling in hypertrophy and heart failure Cardiovasc Res, May 1, 1999; 42(2): 270 - 283. [Full Text] [PDF] |
||||
![]() |
B. J.J.M. Brundel, I. C. Van Gelder, R. H. Henning, A. E. Tuinenburg, L. E. Deelman, R. G. Tieleman, J. G. Grandjean, W. H. Van Gilst, and H. J.G.M. Crijns Gene expression of proteins influencing the calcium homeostasis in patients with persistent and paroxysmal atrial fibrillation Cardiovasc Res, May 1, 1999; 42(2): 443 - 454. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. H. G. Schwinger, J. Wang, K. Frank, J. Muller-Ehmsen, K. Brixius, A. A. McDonough, and E. Erdmann Reduced Sodium Pump {{alpha}}1, {{alpha}}3, and ß1-Isoform Protein Levels and Na+,K+-ATPase Activity but Unchanged Na+-Ca2+ Exchanger Protein Levels in Human Heart Failure Circulation, April 27, 1999; 99(16): 2105 - 2112. [Abstract] [Full Text] [PDF] |
||||
![]() |
U. Kirchhefer, W. Schmitz, H. Scholz, and J. Neumann Activity of cAMP-dependent protein kinase and Ca2+/calmodulin-dependent protein kinase in failing and nonfailing human hearts Cardiovasc Res, April 1, 1999; 42(1): 254 - 261. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. O'Rourke, D. A. Kass, G. F. Tomaselli, S. Kaab, R. Tunin, and E. Marban Mechanisms of Altered Excitation-Contraction Coupling in Canine Tachycardia-Induced Heart Failure, I : Experimental Studies Circ. Res., March 19, 1999; 84(5): 562 - 570. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. R. Shorofsky, R. Aggarwal, M. Corretti, J. M. Baffa, J. M. Strum, B. A. Al-Seikhan, Y. M. Kobayashi, L. R. Jones, W. G. Wier, and C. W. Balke Cellular Mechanisms of Altered Contractility in the Hypertrophied Heart : Big Hearts, Big Sparks Circ. Res., March 5, 1999; 84(4): 424 - 434. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Sato, D. G. Ferguson, H. Sako, G. W. Dorn II, V. J. Kadambi, A. Yatani, B. D. Hoit, R. A. Walsh, and E. G. Kranias Cardiac-specific Overexpression of Mouse Cardiac Calsequestrin Is Associated with Depressed Cardiovascular Function and Hypertrophy in Transgenic Mice J. Biol. Chem., October 23, 1998; 273(43): 28470 - 28477. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. K. B. SIMMERMAN and L. R. JONES Phospholamban: Protein Structure, Mechanism of Action, and Role in Cardiac Function Physiol Rev, October 1, 1998; 78(4): 921 - 947. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. S. Cain, D. R. Meldrum, K. S. Joo, J.-F. Wang, X. Meng, J. C. Cleveland Jr., A. Banerjee, and A. H. Harken Human SERCA2a levels correlate inversely with age in senescent human myocardium J. Am. Coll. Cardiol., August 1, 1998; 32(2): 458 - 467. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Linck, P. Bokník, H. A. Baba, T. Eschenhagen, U. Haverkamp, E. Jäckel, L. R. Jones, U. Kirchhefer, J. Knapp, S. Läer, et al. Long-term Beta Adrenoceptor-Mediated Alteration in Contractility and Expression of Phospholamban and Sarcoplasmic Reticulum Ca++-ATPase in Mammalian Ventricle J. Pharmacol. Exp. Ther., July 1, 1998; 286(1): 531 - 538. [Abstract] [Full Text] |
||||
![]() |
K. Igarashi-Saito, H. Tsutsui, S. Yamamoto, M. Takahashi, S. Kinugawa, H. Tagawa, M. Usui, M. Yamamoto, K. Egashira, and A. Takeshita Role of SR Ca2+-ATPase in contractile dysfunction of myocytes in tachycardia-induced heart failure Am J Physiol Heart Circ Physiol, July 1, 1998; 275(1): H31 - H40. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. Zolk, M. Flesch, G. Nickenig, P. Schnabel, and M. Bohm Alteration of intracellular Ca2+-handling and receptor regulation in hypertensive cardiac hypertrophy: insights from Ren2-transgenic rats Cardiovasc Res, July 1, 1998; 39(1): 242 - 256. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Assayag, D. Charlemagne, I. Marty, J. de Leiris, A. M. Lompre, F. Boucher, P.-E. Valere, S. Lortet, B. Swynghedauw, and S. Besse Effects of sustained low-flow ischemia on myocardial function and calcium-regulating proteins in adult and senescent rat hearts Cardiovasc Res, April 1, 1998; 38(1): 169 - 180. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Hasenfuss Alterations of calcium-regulatory proteins in heart failure Cardiovasc Res, February 1, 1998; 37(2): 279 - 289. [Full Text] [PDF] |
||||
![]() |
A. D Wickenden, R. Kaprielian, Z. Kassiri, J. N Tsoporis, R. Tsushima, G. I Fishman, and P. H Backx The role of action potential prolongation and altered intracellular calcium handling in the pathogenesis of heart failure Cardiovasc Res, February 1, 1998; 37(2): 312 - 323. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. M Phillips, P. Narayan, A. M Gomez, K. Dilly, L. R Jones, W.J. Lederer, and R. A Altschuld Sarcoplasmic reticulum in heart failure: central player or bystander? Cardiovasc Res, February 1, 1998; 37(2): 346 - 351. [Full Text] [PDF] |
||||
![]() |
M. A Movsesian and R. H.G Schwinger Calcium sequestration by the sarcoplasmic reticulum in heart failure Cardiovasc Res, February 1, 1998; 37(2): 352 - 359. [Full Text] [PDF] |
||||
![]() |
M. Meyer and W. H Dillmann Sarcoplasmic reticulum Ca2+-ATPase overexpression by adenovirus mediated gene transfer and in transgenic mice Cardiovasc Res, February 1, 1998; 37(2): 360 - 366. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. P de Tombe Altered contractile function in heart failure Cardiovasc Res, February 1, 1998; 37(2): 367 - 380. [Abstract] [Full Text] [PDF] |
||||
![]() |
G.A. Ng, S. M Cobbe, and G. L Smith Non-uniform prolongation of intracellular Ca2+ transients recorded from the epicardial surface of isolated hearts from rabbits with heart failure Cardiovasc Res, February 1, 1998; 37(2): 489 - 502. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. R.W. Money-Kyrle, C. H. Davies, H. K. Ranu, P. O'Gara, N. Singh Kent, P. A. Poole-Wilson, and S. E. Harding The role of cAMP in the frequency-dependent changes in contraction of guinea-pig cardiomyocytes Cardiovasc Res, February 1, 1998; 37(2): 532 - 540. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. C Smart, K. B Sagar, J. E. Schultz, D. C Warltier, and L. R Jones Injury to the Ca2+ ATPase of the sarcoplasmic reticulum in anesthetized dogs contributes to myocardial reperfusion injury Cardiovasc Res, November 1, 1997; 36(2): 174 - 184. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. F. McTiernan, B. H. Lemster, C. Frye, S. Brooks, A. Combes, and A. M. Feldman Interleukin-1ß Inhibits Phospholamban Gene Expression in Cultured Cardiomyocytes Circ. Res., October 19, 1997; 81(4): 493 - 503. [Abstract] [Full Text] |
||||
![]() |
F. G. Spinale, R. Mukherjee, J. P. Iannini, S. Whitebread, L. Hebbar, M. J. Clair, D. M. Melton, M. H. Cox, P. B. Thomas, and P. B. Marc de Gasparo Modulation of the Renin-Angiotensin Pathway Through Enzyme Inhibition and Specific Receptor Blockade in Pacing-Induced Heart Failure : II. Effects on Myocyte Contractile Processes Circulation, October 7, 1997; 96(7): 2397 - 2406. [Abstract] [Full Text] |
||||
![]() |
J. M. Autry and L. R. Jones Functional Co-expression of the Canine Cardiac Ca2+ Pump and Phospholamban in Spodoptera frugiperda (Sf21) Cells Reveals New Insights on ATPase Regulation J. Biol. Chem., June 20, 1997; 272(25): 15872 - 15880. [Abstract] [Full Text] [PDF] |
||||
![]() |
K Davia, C.H Davies, and S.E Harding Effects of inhibition of sarcoplasmic reticulum calcium uptake on contraction in myocytes isolated from failing human ventricle Cardiovasc Res, January 1, 1997; 33(1): 88 - 97. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. L. Koss and E. G. Kranias Phospholamban: A Prominent Regulator of Myocardial Contractility Circ. Res., December 1, 1996; 79(6): 1059 - 1063. [Full Text] |
||||
![]() |
R. H.G. Schwinger, M. Bohm, U. Schmidt, P. Karczewski, U. Bavendiek, M. Flesch, E.-G. Krause, and E. Erdmann Unchanged Protein Levels of SERCA II and Phospholamban but Reduced Ca2+ Uptake and Ca2+-ATPase Activity of Cardiac Sarcoplasmic Reticulum From Dilated Cardiomyopathy Patients Compared With Patients With Nonfailing Hearts Circulation, December 1, 1995; 92(11): 3220 - 3228. [Abstract] [Full Text] |
||||
![]() |
L. R. Nimer, D. H. Needleman, S. L. Hamilton, J. Krall, and M. A. Movsesian Effect of Ryanodine on Sarcoplasmic Reticulum Ca2+ Accumulation in Nonfailing and Failing Human Myocardium Circulation, November 1, 1995; 92(9): 2504 - 2510. [Abstract] [Full Text] |
||||
![]() |
J. Ross Jr, T. Miura, M. Kambayashi, G. P. Eising, and K.-H. Ryu Adrenergic Control of the Force-Frequency Relation Circulation, October 15, 1995; 92(8): 2327 - 2332. [Abstract] [Full Text] |
||||
![]() |
E. Kiss, N. A. Ball, E. G. Kranias, and R. A. Walsh Differential Changes in Cardiac Phospholamban and Sarcoplasmic Reticular Ca2+-ATPase Protein Levels : Effects on Ca2+ Transport and Mechanics in Compensated Pressure-Overload Hypertrophy and Congestive Heart Failure Circ. Res., October 1, 1995; 77(4): 759 - 764. [Abstract] [Full Text] |
||||
![]() |
M. Meyer, W. Schillinger, B. Pieske, C. Holubarsch, C. Heilmann, H. Posival, G. Kuwajima, K. Mikoshiba, H. Just, and G. Hasenfuss Alterations of Sarcoplasmic Reticulum Proteins in Failing Human Dilated Cardiomyopathy Circulation, August 15, 1995; 92(4): 778 - 784. [Abstract] [Full Text] |
||||
![]() |
Z. Wang, B. Nolan, W. Kutschke, and J. A. Hill Na+-Ca2+ Exchanger Remodeling in Pressure Overload Cardiac Hypertrophy J. Biol. Chem., May 18, 2001; 276(21): 17706 - 17711. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. DAVIA, R. J. HAJJAR, C. M. N. TERRACCIANO, N. S. KENT, H. K. RANU, P. O'GARA, A. ROSENZWEIG, and S. E. HARDING Functional alterations in adult rat myocytes after overexpression of phospholamban with use of adenovirus Physiol Genomics, August 31, 1999; 1(2): 41 - 50. [Abstract] [Full Text] [PDF] |
||||
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1994 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |